Canobbio L - Search Results

1

Role of blood groups as prognostic factors in primary breast cancer.

Costantini M, Fassio T, Canobbio L, Landucci M, Resasco M, Boccardo F. Costantini M, et al. Among authors: canobbio l. Oncology. 1990;47(4):308-12. doi: 10.1159/000226839. Oncology. 1990. PMID: 2367058

2

Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancer.

Boccardo F, Canobbio L, Resasco M, Decensi AU, Pastorino G, Brema F. Boccardo F, et al. Among authors: canobbio l. J Cancer Res Clin Oncol. 1990;116(5):503-6. doi: 10.1007/BF01613002. J Cancer Res Clin Oncol. 1990. PMID: 2229142 Clinical Trial.

3

Phase-II study of Navelbine in advanced breast cancer.

Canobbio L, Boccardo F, Pastorino G, Brema F, Martini C, Resasco M, Santi L. Canobbio L, et al. Semin Oncol. 1989 Apr;16(2 Suppl 4):33-6. Semin Oncol. 1989. PMID: 2711204 No abstract available.

4

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-alpha.

Canobbio L, Rubagotti A, Miglietta L, Cannata D, Curotto A, Amoroso D, Boccardo F. Canobbio L, et al. J Cancer Res Clin Oncol. 1995;121(12):753-6. doi: 10.1007/BF01213322. J Cancer Res Clin Oncol. 1995. PMID: 7499447 Clinical Trial.

5

Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patients.

Gasparini G, Canobbio L, Galligioni E, Fassio T, Brema F, Crivellari D, Villalta D, Di Fronzo G, Talamini R, Monfardini S. Gasparini G, et al. Among authors: canobbio l. Eur J Cancer Clin Oncol. 1987 Oct;23(10):1451-9. doi: 10.1016/0277-5379(87)90086-1. Eur J Cancer Clin Oncol. 1987. PMID: 2960532

6

Somatuline and tamoxifen in postmenopausal breast cancer patients.

Canobbio L, Cannata D, Miglietta L, Boccardo F. Canobbio L, et al. Ann N Y Acad Sci. 1993 Nov 30;698:362-6. doi: 10.1111/j.1749-6632.1993.tb17227.x. Ann N Y Acad Sci. 1993. PMID: 8279776 Clinical Trial. No abstract available.

7

Somatuline (BIM 23014) and tamoxifen treatment of postmenopausal breast cancer patients: clinical activity and effect on insulin-like growth factor-I (IGF-I) levels.

Canobbio L, Cannata D, Miglietta L, Boccardo F. Canobbio L, et al. Anticancer Res. 1995 Nov-Dec;15(6B):2687-90. Anticancer Res. 1995. PMID: 8669848 Clinical Trial.

8

Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II study.

Miglietta L, Canobbio L, Granetto C, Vannozzi MO, Esposito M, Boccardo F. Miglietta L, et al. Among authors: canobbio l. J Cancer Res Clin Oncol. 1997;123(7):407-10. doi: 10.1007/BF01240125. J Cancer Res Clin Oncol. 1997. PMID: 9260594 Clinical Trial.

9

Low activity of circadian continuous fluorodeoxyuridine (fudr) chemotherapy in poor-prognosis metastatic renal-cancer.

Miglietta L, Canobbio L, Cannata D, Curotto A, Bertiriboli F, Giuliani L, Boccardo F. Miglietta L, et al. Among authors: canobbio l. Oncol Rep. 1994 Jan;1(1):121-3. doi: 10.3892/or.1.1.121. Oncol Rep. 1994. PMID: 21607319

10

Plasma retinol levels and side effects following high-dose retinyl acetate in breast cancer patients.

Resasco M, Canobbio L, Trave F, Valenti G, Mazzoni A, Canti G, Boccardo F, Nicolin A. Resasco M, et al. Among authors: canobbio l. Anticancer Res. 1988 Nov-Dec;8(6):1319-23. Anticancer Res. 1988. PMID: 3218964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters